CAR-T vs Monjuvi: A Battle of Complexity vs Accessibility
Despite being precision based targeted therapies, Chimeric Antigen Receptor T-Cell therapy (CAR-T) and Monjuvi (tafasitamab-cxix)…
Dr. Banisetti SravyaApril 30, 2026